Pulmonary thromboendarterectomy in a combined thrombophilia patient
Yükleniyor...
Dosyalar
Tarih
2019
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
CLINICS CARDIVE PUBL PTY LTD
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially correctable cause of secondary pulmonary hypertension. Surgical treatment remains the primary treatment for patients with CTEPH. Pulmonary thromboendarterectomy (PEA) with deep hypothermic circulatory arrest is the standard and recommended surgical technique for the treatment of these patients. The prevalence of CTEPH after an acute pulmonary thromboembolism (PTE) has been found in various studies to be between 0.6 and 8.8%. Mortality rates in elective PEA cases with CTEPH are reported to be between 1.9 and 4.5%. We report on a 50-year-old female patient with combined inherited thrombophilia, including protein C and protein S deficiencies, who was diagnosed with CTEPH and was successfully treated with pulmonary thromboendarterectomy.
Açıklama
Anahtar Kelimeler
protein C, protein S, pulmonary embolism, thromboendarterectomy
Kaynak
CARDIOVASCULAR JOURNAL OF AFRICA
WoS Q Değeri
Q4
Scopus Q Değeri
Q3
Cilt
30
Sayı
1
Künye
Akbayrak, H., Tekumit, H. (2019). Pulmonary Thromboendarterectomy İn A Combined Thrombophilia Patient. Cardiovasc J Afr, 30,(1), e4-e6.
